S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
OTCMKTS:OPYGY

Public Joint Stock Company Polyus Stock Forecast, Price & News

$81.15
+0.03 (+0.04%)
(As of 01/14/2022 03:54 PM ET)
Add
Compare
Today's Range
$78.50
$81.15
50-Day Range
$81.11
$111.64
52-Week Range
$78.50
$123.00
Volume
6,500 shs
Average Volume
3,575 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive OPYGY News and Ratings via Email

Sign-up to receive the latest news and ratings for Public Joint Stock Company Polyus and its competitors with MarketBeat's FREE daily newsletter.


Public Joint Stock Company Polyus logo

About Public Joint Stock Company Polyus

Polyus PJSC engages in the gold mining and geological exploration activities. It operates through the following business segments: Krasnoyarsk, Irkutsk Alluvial Gold, Irkutsk Ore, Yakutsk (Kurkhan), Magadan, Exploration, Construction, and Other. The company was founded on March 17, 2006 and is headquartered in Moscow, Russia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Gold
Sub-Industry
N/A
Current Symbol
OTCMKTS:OPYGY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

Company Calendar

Last Earnings
11/23/2021
Today
1/18/2022

MarketRank

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Public Joint Stock Company Polyus (OTCMKTS:OPYGY) Frequently Asked Questions

Is Public Joint Stock Company Polyus a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Public Joint Stock Company Polyus in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Public Joint Stock Company Polyus stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPYGY, but not buy additional shares or sell existing shares.
View analyst ratings for Public Joint Stock Company Polyus
or view top-rated stocks.

How has Public Joint Stock Company Polyus' stock been impacted by Coronavirus?

Public Joint Stock Company Polyus' stock was trading at $66.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OPYGY shares have increased by 22.0% and is now trading at $81.15.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Public Joint Stock Company Polyus?

Public Joint Stock Company Polyus saw a increase in short interest in December. As of December 31st, there was short interest totaling 600 shares, an increase of 500.0% from the December 15th total of 100 shares. Based on an average daily volume of 1,900 shares, the short-interest ratio is presently 0.3 days.
View Public Joint Stock Company Polyus' Short Interest
.

How were Public Joint Stock Company Polyus' earnings last quarter?

Public Joint Stock Company Polyus (OTCMKTS:OPYGY) posted its quarterly earnings data on Tuesday, November, 23rd. The company reported $2.43 earnings per share for the quarter. The business earned $1.40 billion during the quarter.
View Public Joint Stock Company Polyus' earnings history
.

Who are Public Joint Stock Company Polyus' key executives?

Public Joint Stock Company Polyus' management team includes the following people:
  • Pavel Sergeevich Grachev, Chief Executive Officer & Director
  • Vladimir Anatolyevich Polin, Director & Senior Vice President-Operations
  • Mikhail Borisovich Stiskin, Director, Deputy CEO-Economics & Finance
  • Alexander Shitov, Vice President-Control & Compliance
  • Sergey Lobov, Vice President-Mineral Resources

What is Public Joint Stock Company Polyus' stock symbol?

Public Joint Stock Company Polyus trades on the OTCMKTS under the ticker symbol "OPYGY."

How do I buy shares of Public Joint Stock Company Polyus?

Shares of OPYGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Public Joint Stock Company Polyus' stock price today?

One share of OPYGY stock can currently be purchased for approximately $81.15.

What is Public Joint Stock Company Polyus' official website?

The official website for Public Joint Stock Company Polyus is polyus.com.

Where are Public Joint Stock Company Polyus' headquarters?

Public Joint Stock Company Polyus is headquartered at Tverskoy Bul'var, Dom 15, Stroyeniye 1, MOSCOW, 123104, Russian Federation.

How can I contact Public Joint Stock Company Polyus?

Public Joint Stock Company Polyus' mailing address is Tverskoy Bul'var, Dom 15, Stroyeniye 1, MOSCOW, 123104, Russian Federation. The company can be reached via phone at (495) 641-3377.


This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.